Hepatic miR-363 promotes nonalcoholic fatty liver disease by suppressing INSIG1
- 3 August 2024
- journal article
- research article
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 134, 109717
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Endoplasmic reticulum stress in liver diseasesHepatology, 2022
- Discovery of an insulin‐induced gene binding compound that ameliorates nonalcoholic steatohepatitis by inhibiting sterol regulatory element‐binding protein–mediated lipogenesisHepatology, 2022
- Apigenin, flavonoid component isolated from Gentiana veitchiorum flower suppresses the oxidative stress through LDLR-LCAT signaling pathwayBiomedicine & Pharmacotherapy, 2020
- MicroRNA‐223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in HepatocytesHepatology, 2019
- Apigenin prevents metabolic syndrome in high-fructose diet-fed mice by Keap1-Nrf2 pathwayBiomedicine & Pharmacotherapy, 2018
- Apigenin: A dietary flavonoid with diverse anticancer propertiesCancer Letters, 2018
- Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemiaHepatology, 2014
- Ablation of gp78 in Liver Improves Hyperlipidemia and Insulin Resistance by Inhibiting SREBP to Decrease Lipid BiosynthesisCell Metabolism, 2012
- Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular CarcinomaCancer Cell, 2011
- Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptakeCell Metabolism, 2006